Myocardial Protective Effect of Tezosentan, an Endothelin Receptor Antagonist, for Ischemia-Reperfusion Injury in Experimental Heart Failure Models

The myocardial protective effects of endothelin antagonist in ischemic cardiomyopathy (ICMP), doxorubicin-induced cardiomyopathy (DOX) and pressure-overload hypertrophy by transverse aortic constriction (TAC) models have been predicted to be different. The objective of this experiment, therefore, is...

Descripción completa

Detalles Bibliográficos
Autores principales: Ryu, Se Min, Kim, Hark Jei, Cho, Kyu Ran, Jo, Won-Min
Formato: Texto
Lenguaje:English
Publicado: The Korean Academy of Medical Sciences 2009
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2752756/
https://www.ncbi.nlm.nih.gov/pubmed/19794971
http://dx.doi.org/10.3346/jkms.2009.24.5.782

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2752756/
https://www.ncbi.nlm.nih.gov/pubmed/19794971
http://dx.doi.org/10.3346/jkms.2009.24.5.782

Ejemplares similares